Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience

BACKGROUND: Patients with triple-negative primary breast cancer (TNBC) who have residual invasive carcinoma after neoadjuvant chemotherapy have poor prognosis. Proven adjuvant approaches to reduce the risk of recurrence and improve outcome in patients with non-pathological complete response (non-pCR...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Breast Care (Basel)
Main Authors: Stoetzer, Oliver, Di Gioia, Dorit, Issels, Rolf Dieter, Abdel-Rahman, Sultan, Mansmann, Ulrich, Lindner, Lars Hartwin, Gluz, Oleg, Würstlein, Rachel, Braun, Michael, Hamann, Moritz, Edler von Koch, Franz, Harbeck, Nadia, Salat, Christoph
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114059/
https://ncbi.nlm.nih.gov/pubmed/34012372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507473
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares